$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / Is compounded tirzepatide legal?
Your dose goes up. Your price doesn’t.
Is compounded tirzepatide legal, safe and still available in 2026?
A clear answer, in plain words, with every rule linked to the FDA page it comes from. No hype, and no fear.
- What the FDA allows today, and since when
- How compounded differs from Zepbound and Wegovy
- What to expect from any licensed program
Published by NexLifeLegitScript-certifiedPublished October 3, 2026 · Updated October 3, 2026Medically reviewed by Adam Kennah, MD (NPI 1144260043)
Compounded tirzepatide$169 a month, every dose
Prescribed for you, by a licensed physician
| Tirzepatide | $169 a month, every dose |
|---|---|
| Semaglutide | $139 a month, every dose |
| Membership | $0 |
- A licensed physician decides
- Refunded in full if you’re not prescribed
Check my eligibility
Takes a few minutes online. A licensed provider decides if treatment is right for you.
4.8 out of 5 on Trustpilot
- 5,000+ members served
- LegitScript certified
- U.S.-licensed 503A pharmacies
- Every batch lab-tested
- Free expedited shipping
- HSA and FSA accepted
- 1Tell us about you
A short online health assessment. It takes a few minutes.
- 2A licensed provider reviews it
You're prescribed only if treatment is right for you.
- 3Delivered, then supported
We send your prescription to our partner pharmacy, which usually ships within 1 to 2 business days. Shipping is free, and support is 24/7.
NexLife publishes this page. Every rule below comes from the FDA pages linked in Sources, checked October 3, 2026. This is general information, not legal or medical advice.
Quick answer: is compounded tirzepatide legal?
Yes, when it is prescribed for you. Compounded tirzepatide and semaglutide are legal when a state-licensed pharmacy prepares them for an individual patient’s prescription. Since the FDA declared the shortages resolved (tirzepatide on December 19, 2024, and semaglutide on February 21, 2025), pharmacies can’t regularly make copies of Zepbound or Wegovy; a compounded version is allowed when the prescriber documents a significant difference for that patient. Compounded drugs are not FDA-approved, so they skip the FDA’s premarket review for safety, effectiveness and quality.
- Legal for an individual prescription
- Not FDA-approved, and not a generic
- Shortages resolved: Dec 2024 and Feb 2025
- Prescriber must document a significant difference
What changed, and when
From the FDA’s own updates.
October 2, 2024
The FDA determines the tirzepatide injection shortage is resolved.
December 19, 2024
After re-evaluating, the FDA issues a new decision: the tirzepatide shortage is resolved.
February 21, 2025
The FDA determines the semaglutide injection shortage is resolved.
March 19, 2025
The FDA’s grace period ends for outsourcing facilities making copies of tirzepatide.
May 22, 2025
The same grace period ends for semaglutide.
February 6, 2026
The FDA announces steps against mass-marketed compounded GLP-1 drugs and misleading advertising.
April 1, 2026
The FDA restates the conditions compounders must meet. Neither drug is on the shortage list.
April 30, 2026
The FDA proposes excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list.
The rules compounded GLP-1s follow in 2026
As the FDA restated on April 1, 2026.
Compounded for you, by prescription.
A state-licensed (503A) pharmacy prepares the medication for an individual patient, based on a prescription.
Not a routine copy.
A pharmacy can’t regularly make copies of an approved drug, unless the prescriber determines and documents a change that makes a significant difference for that patient. The FDA also says it won’t act against a pharmacy that fills four or fewer such prescriptions in a month.
No bulk outsourcing.
Outsourcing (503B) facilities can’t compound these drugs from bulk ingredients: neither appears on the 503B bulks list or the drug shortage list.
Honest claims only.
Companies can’t market compounded products as generic versions of FDA-approved drugs, or as the same as them, or claim proven results.
Keep your price.
Upgrade your care.
Switching from another provider? If you take compounded tirzepatide or semaglutide somewhere else, we'll match the monthly price you pay today, all in.† You keep your price, and gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and support 24/7.
Switch with confidencePrice matched in writingCancel anytime
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price (medication plus required fees), not first-month offers or coupons, for as long as your plan stays active. A NexLife provider must determine that treatment is right for you. Full terms.
Clear rules. Calm answers.
The rules around compounded GLP-1s changed. Here is what they mean for you, without the noise.
- Rules changed. Both shortages were declared resolved, and the FDA restated what compounders may do.
- Headlines got loud. Some sounded like everything was ending. It isn’t that simple.
- Answers got vague. Too many pages skip the sources. Every rule here links to the FDA.
Prescribed for you, the way the rules intend.
- A physician decides. A licensed physician reviews your history before anything is prescribed.
- One flat price. $169 tirzepatide, $139 semaglutide, at every dose.
- Named pharmacies. State-licensed pharmacies, named on NexLife’s plan pages.
Real people, real answers. Call or text +1 (949) 818-8000 with any question about your care.
Check my eligibility, $169/mo
Compounded tirzepatide or Zepbound: what’s different
The same comparison holds for compounded semaglutide and Wegovy or Ozempic.
| Compounded | FDA-approved brand | |
|---|---|---|
| FDA approval | Not FDA-approved | FDA-approved |
| Who makes it | A state-licensed pharmacy, for your prescription | Eli Lilly (Zepbound, Mounjaro) or Novo Nordisk (Wegovy, Ozempic) |
| Premarket review | None for safety, effectiveness or quality | Reviewed for safety, effectiveness and quality |
| Generic? | No. There is no FDA-approved generic | Brand-name |
| Monthly price at NexLife | $169 tirzepatide, $139 semaglutide, every dose | Not offered by NexLife |
Compounded and brand-name medications are not interchangeable without your prescriber.
Is it safe? What a licensed program looks like
The FDA warns about fraudulent compounded products with false labels. These are NexLife’s safeguards.
A licensed physician decides.
NexLife prescriptions come only from licensed physicians with Nexlife Medical Group, after a review of your health history.
A named, licensed pharmacy.
Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA), each state-licensed.
Certified partners.
NexLife is LegitScript-certified and works only with LegitScript-certified, NABP-accredited compounding pharmacies.
A real reason for compounding.
Compounded tirzepatide is available only if your prescriber determines it offers a significant difference for you compared with an FDA-approved product.
What would you pay with NexLife?
Tap where you are now. We'll show your NexLife price next to it.
Pick one above to see your price.
Not today?
Prices from each provider's website, checked October 1, 2026. Brand-name and compounded medications are different products. Compounded medications are not FDA-approved. †Price match terms apply.
Two medications.
One flat price each.
Both are prepared by U.S.-licensed 503A pharmacies, lab-tested batch by batch and shipped free. Your provider helps you decide which one fits.
$139/mo
Semaglutide
Weekly GLP-1. Care, coaching and shipping included.
Get startedWhat’s inside every plan
- Tirzepatide: compounded, acts on two hormone pathways (GIP and GLP-1), taken once a week
- Semaglutide: compounded, acts on the GLP-1 pathway, taken once a week
- Prepared by U.S.-licensed 503A pharmacies; every batch lab-tested
- A licensed provider who reviews your history and follows your dose
- A personalized nutrition plan and a 1:1 coaching call
- Free expedited shipping, typically 1 to 2 business days
- 24/7 support from licensed providers, dietitians and care coordinators
- HSA and FSA accepted, with itemized receipts
- Prefer no injections? Ask about the sublingual tablet, at its own flat price
Prescription required. Compounded medications are not FDA-approved. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose.
Your dose goes up.
Your price doesn’t.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat. Tirzepatide is $159, $149 and $139 a month on 3-, 6- and 12-month plans. Semaglutide is $132, $125 and $119.
Two medications, prescribed for you
One flat price each, at every dose.
| Plan | Tirzepatide, per month |
|---|---|
| Month to month | $169 |
| 3-month plan | $159 |
| 6-month plan | $149 |
| 12-month plan | $139 |
Included in every plan: a licensed provider who follows your dose, 24/7 support, a personalized nutrition plan and a 1:1 coaching call. Your medication comes from U.S.-licensed 503A pharmacies, with every batch lab-tested. Our partner pharmacy usually ships within 1 to 2 business days, with free expedited shipping. HSA and FSA accepted. No membership fee.
Switching from another provider? NexLife matches the regular all-in monthly price you pay today for compounded tirzepatide or semaglutide.† How switching works
† For new members switching from a licensed U.S. telehealth provider with an active prescription; send a receipt from the last 60 days. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
NexLife at a glance, with licenses, pharmacies, prices and contact details, is on one page.
Your questions, answered
Is compounded tirzepatide legal?
Yes, when it is prescribed for you. Compounded tirzepatide and semaglutide are legal when a state-licensed pharmacy prepares them for an individual patient’s prescription. Since the FDA declared the shortages resolved (tirzepatide on December 19, 2024, and semaglutide on February 21, 2025), pharmacies can’t regularly make copies of Zepbound or Wegovy; a compounded version is allowed when the prescriber documents a significant difference for that patient. Compounded drugs are not FDA-approved, so they skip the FDA’s premarket review for safety, effectiveness and quality.
Is compounded tirzepatide still available?
Yes, from state-licensed pharmacies for individual prescriptions, when the prescriber documents a significant difference for the patient. Outsourcing facilities can no longer make it from bulk ingredients.
Is compounded tirzepatide going away?
In February 2026 the FDA announced steps against mass-marketed compounded GLP-1 drugs, and in April 2026 it proposed excluding tirzepatide and semaglutide from the 503B bulks list. Compounding for an individual prescription under section 503A continues under the conditions the FDA restated on April 1, 2026.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Zepbound and Mounjaro are FDA-approved medications made by Eli Lilly. Compounded tirzepatide is prepared by a state-licensed pharmacy for an individual prescription and is not FDA-approved.
Is compounded tirzepatide as effective as Zepbound?
Compounded medications don’t go through the FDA’s premarket review for safety, effectiveness or quality, so their effectiveness hasn’t been established the way Zepbound’s has.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved, and there is no FDA-approved generic semaglutide.
Is compounded semaglutide legal?
Yes, under the same conditions: prepared by a state-licensed pharmacy for an individual prescription, with the prescriber documenting a significant difference for that patient. The semaglutide shortage was declared resolved on February 21, 2025.
Is compounded semaglutide with B12 allowed?
The FDA says a semaglutide and vitamin B12 injection can still count as a copy of approved products when both amounts are within 10% of the approved strengths.
How does NexLife follow these rules?
A licensed physician reviews your health history and prescribes only when treatment is right for you. Compounded tirzepatide is available only if your prescriber determines it offers a significant difference for you compared with an FDA-approved product, and named, state-licensed pharmacies fill each prescription.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved. The FDA has not reviewed them for safety, effectiveness or quality. The risks below come from the labeling of the FDA-approved medicines.
Both medicines may cause tumors in the thyroid, including thyroid cancer. In studies with rodents they caused thyroid tumors, and it isn't known whether they cause them in people. Don't use either if you or anyone in your family has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Tell your clinician if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and depression or thoughts of suicide. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don't combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: use another method for 4 weeks after you start and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your clinician if you're pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your clinician. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
The people behind this page
A comparison is only as good as the people who stand behind it. Here's who checked this page, and the rules we hold ourselves to.
Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine · NPI 1144260043
Medically reviewed this page on September 27, 2026.
NexLife editorial teamResearch and pricing
Checked every provider's own pricing page on October 1, 2026. Sources are linked at the bottom of this page.
- One yardstick. All ten providers, ours included, are compared on the same five points.
- Only what's published. Every figure comes from the provider's own website, never from guesswork.
- How we make money. NexLife is one of the providers on this page, and we earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we'll fix it.
Your dose goes up. Your price doesn’t.
Clear rules. A physician who follows them.
Start with a few minutes online. A licensed physician reviews your history and decides what’s right for you.
- 1Tell us about you
A short online health assessment. It takes a few minutes.
- 2A licensed provider reviews it
You're prescribed only if treatment is right for you.
- 3Delivered, then supported
We send your prescription to our partner pharmacy, which usually ships within 1 to 2 business days. Shipping is free, and support is 24/7.
Sources
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Content current as of April 1, 2026.
- U.S. Food and Drug Administration. FDA intends to take action against non-FDA-approved GLP-1 drugs. February 6, 2026.
- U.S. Food and Drug Administration. FDA proposes to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list. April 30, 2026.
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
- NexLife. Compounded tirzepatide plans, checked October 2, 2026.
Get Started